Works matching IS 11732563 AND DT 2022 AND VI 42 AND IP 2

Results: 8

Opicapone for the Treatment of Parkinson's Disease "Off" Episodes: Pharmacology and Clinical Considerations.

Published in:

Clinical Drug Investigation, 2022, v. 42, n. 2, p. 127, doi. 10.1007/s40261-021-01109-3

By:

Berger, Amnon A.;
Robinson, Christopher;
Winnick, Ariel;
Izygon, Jonathan;
Jacob, Binil M.;
Noonan, Mackenzie J.;
Kaye, Alan D.;
Kaye, Jessica S.;
Kaye, Adam M.;
Cornett, Elyse M.;
Shah, Rutvij J.;
Viswanath, Omar;
Urits, Ivan

Publication type:

Article

Safety, Pharmacokinetics and Pharmacodynamics of DS-1040, in Combination with Thrombectomy, in Japanese Patients with Acute Ischemic Stroke.

Published in:

Clinical Drug Investigation, 2022, v. 42, n. 2, p. 137, doi. 10.1007/s40261-021-01112-8

By:

Sakai, Nobuyuki;
Takeuchi, Masataka;
Imamura, Hirotoshi;
Shimamura, Norihito;
Yoshimura, Shinichi;
Naito, Hiromichi;
Kimura, Naoto;
Masuo, Osamu;
Hirotsune, Nobuyuki;
Morita, Kenichi;
Toyoda, Kazunori;
Yamagami, Hiroshi;
Ishihara, Hideyuki;
Nakatsu, Takafumi;
Miyoshi, Naoki;
Suda, Miharu;
Fujimoto, Shigeru

Publication type:

Article

Stepping Forward to the Next Level: Totality of Evidence for the First High-Concentration Adalimumab Biosimilar, CT-P17.

Published in:

Clinical Drug Investigation, 2022, v. 42, n. 2, p. 103, doi. 10.1007/s40261-021-01107-5

By:

Viapiana, Ombretta;
Lee, Soohyun;
Yoon, SangWook;
Fautrel, Bruno

Publication type:

Article

Adverse Events with d-penicillamine Therapy in Hepatic Wilson's Disease: A Single-Center Retrospective Audit.

Published in:

Clinical Drug Investigation, 2022, v. 42, n. 2, p. 177, doi. 10.1007/s40261-022-01117-x

By:

Kumar, Sanjay;
Patra, Biswa Ranjan;
Irtaza, Mohammed;
Rao, Praveen Kumar;
Giri, Suprabhat;
Darak, Harish;
Gopan, Amrit;
Kale, Aditya;
Shukla, Akash

Publication type:

Article

Comparative Bioavailability Study of a New Vitamin D3 Orodispersible Film Versus a Marketed Oral Solution in Healthy Volunteers.

Published in:

Clinical Drug Investigation, 2022, v. 42, n. 2, p. 151, doi. 10.1007/s40261-021-01113-7

By:

Radicioni, Milko;
Caverzasio, Carol;
Rovati, Stefano;
Giori, Andrea Maria;
Cupone, Irma;
Marra, Fabio;
Mautone, Giuseppe

Publication type:

Article

Therapeutic Drug Monitoring-Guided Adjuvant Tamoxifen Dosing in Patients with Early Breast Cancer: A Cost-Effectiveness Analysis from the Prospective TOTAM Trial.

Published in:

Clinical Drug Investigation, 2022, v. 42, n. 2, p. 163, doi. 10.1007/s40261-021-01114-6

By:

Braal, C. Louwrens;
Kleijburg, Anne;
Jager, Agnes;
Koolen, Stijn L. W.;
Mathijssen, Ron H. J.;
Corro Ramos, Isaac;
Wetzelaer, Pim;
Uyl-de Groot, Carin A.

Publication type:

Article

Next-Generation Sequencing Liquid Biopsy-Guided Osimertinib Rechallenge in EGFR-Mutated Advanced Non-Small-Cell Lung Cancer Patients.

Published in:

Clinical Drug Investigation, 2022, v. 42, n. 2, p. 185, doi. 10.1007/s40261-021-01116-4

By:

Fuchs, Vered;
Kian, Waleed;
Lichtenberg, Rachel;
Cooper, Jonah M.;
Remilah, Areen A.;
Levin, Daniel;
Peled, Nir;
Roisman, Laila C.

Publication type:

Article

Informing and Empowering Patients and Clinicians to Make Evidence-Supported Outcome-Based Decisions in Relation to SGLT2 Inhibitor Therapies: The Use of the Novel Years of Drug administration (YoDa) Concept.

Published in:

Clinical Drug Investigation, 2022, v. 42, n. 2, p. 113, doi. 10.1007/s40261-021-01105-7

By:

Varadhan, Lakshminarayanan;
Saravanan, Ponnusamy;
Ali, Sarah N.;
Hanif, Wasim;
Patel, Vinod

Publication type:

Article